|
CWF19L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.43569966815483E-10 |
| Normal-vs-Stage3 |
4.66293670342566E-14 |
| Normal-vs-Stage4 |
2.57370014189462E-10 |
| Stage1-vs-Stage2 |
5.697000E-01 |
| Stage1-vs-Stage3 |
7.527400E-01 |
| Stage1-vs-Stage4 |
3.682200E-01 |
| Stage2-vs-Stage3 |
4.350000E-01 |
| Stage2-vs-Stage4 |
2.044400E-01 |
| Stage3-vs-Stage4 |
4.274200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
9.88098491916389E-15 |
| Normal-vs-Asian |
8.08710000077539E-08 |
| Caucasian-vs-AfricanAmerican |
5.916400E-01 |
| Caucasian-vs-Asian |
3.348600E-01 |
| AfricanAmerican-vs-Asian |
2.608200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.31459296173853E-12 |
| Male-vs-Female |
5.481000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.68998148808441E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.59261492882479E-12 |
| Normal-vs-Extreme_Obese |
4.86489959428127E-10 |
| Normal_Weight-vs-Extreme_Weight |
4.213200E-01 |
| Normal_Weight-vs-Obese |
4.770800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.554400E-01 |
| Extreme_Weight-vs-Obese |
9.523600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.523800E-01 |
| Obese-vs-Extreme_Obese |
2.084400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.577190E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.39350000824845E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.531600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.977010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.369600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.875900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.878400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.963200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
5.834400E-02 |
| Normal-VS-Unclassified PRCC |
2.835299772741E-10 |
| Type1 PRCC-VS-Type2 PRCC |
9.758600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.312200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.136200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.365200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.468600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.196400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.79830000002212E-06 |
| Normal-vs-N2 |
1.62569957495862E-12 |
| N0-vs-N1 |
1.412420E-01 |
| N0-vs-N2 |
1.091830E-02 |
| N1-vs-N2 |
8.958400E-03 |
|
|
